What is the management approach for acute respiratory distress syndrome (ARDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Respiratory Distress Syndrome (ARDS)

The management of ARDS should follow a structured approach including lung-protective ventilation strategies, appropriate PEEP settings, prone positioning, and adjunctive therapies such as corticosteroids and neuromuscular blockers based on disease severity. 1, 2

Diagnosis and Classification

ARDS is classified based on the PaO₂/FiO₂ ratio:

  • Mild: 201-300 mmHg
  • Moderate: 101-200 mmHg
  • Severe: ≤100 mmHg 2

Diagnostic criteria include:

  • Onset within one week of a known insult or worsening respiratory symptoms
  • Bilateral pulmonary opacities on chest imaging
  • Respiratory failure not explained by cardiac failure or fluid overload 3

Core Management Strategies

Lung-Protective Ventilation

  • Use low tidal volumes (4-8 mL/kg predicted body weight) 1
  • Maintain plateau pressure ≤30 cmH₂O
  • Target driving pressure <15 cmH₂O 2
  • Calculate predicted body weight using:
    • Males: PBW (kg) = 50 + 0.91 × (height [cm] − 152.4)
    • Females: PBW (kg) = 45.5 + 0.91 × (height [cm] − 152.4) 2

PEEP Strategy

  • For moderate to severe ARDS: Use higher PEEP without lung recruitment maneuvers (conditional recommendation, low to moderate certainty) 1
  • For all ARDS patients: Minimum PEEP of 5 cmH₂O 2
  • Avoid prolonged lung recruitment maneuvers in moderate to severe ARDS (strong recommendation, moderate certainty) 1

Prone Positioning

  • Implement prone positioning for >12 hours/day in severe ARDS (PaO₂/FiO₂ ≤100 mmHg) 2
  • Initiate early rather than as a rescue strategy 2

Adjunctive Therapies Based on Severity

For All ARDS Patients

  • Conservative fluid management after initial resuscitation 2
  • Prophylaxis for stress ulcers and venous thromboembolism 3
  • Target PaO₂ between 70-90 mmHg or SaO₂ between 92-97% 2

For Moderate to Severe ARDS

  • Corticosteroids: Suggested for patients with ARDS (conditional recommendation, moderate certainty) 1, 2

For Severe ARDS (PaO₂/FiO₂ ≤100 mmHg)

  • Neuromuscular blockers: Suggested in early severe ARDS (conditional recommendation, low certainty) 1, 2
  • VV-ECMO: Consider in selected patients with severe ARDS (conditional recommendation, low certainty) 1
    • Best candidates: PaO₂/FiO₂ <80 mmHg, pH <7.25 with PaCO₂ >60 mmHg, early ARDS course (<7 days), and reversible etiology 2

Management Algorithm by ARDS Severity

Severity PaO₂/FiO₂ Primary Interventions
Mild 201-300 mmHg • Lung-protective ventilation
• Low PEEP strategy (5-10 cmH₂O)
• Conservative fluid management
Moderate 101-200 mmHg • Lung-protective ventilation
• Higher PEEP strategy
• Consider corticosteroids
• Conservative fluid management
Severe ≤100 mmHg • Lung-protective ventilation
• Higher PEEP strategy
• Prone positioning >12h/day
• Neuromuscular blockers
• Corticosteroids
• Consider VV-ECMO in selected patients

Common Pitfalls and Caveats

  • Avoid excessive tidal volumes even in patients without ARDS, as observational evidence suggests benefit from limiting tidal volumes in all mechanically ventilated patients 4
  • Avoid inappropriate PEEP in mild ARDS as it may impede venous return without significant benefit 2
  • Monitor for hemodynamic instability with higher PEEP strategies, particularly in patients with vasodilation 2
  • Do not delay prone positioning in severe ARDS; implement early rather than as a rescue strategy 2
  • Avoid high-frequency oscillatory ventilation as routine therapy in ARDS (may be considered only as rescue therapy) 5, 6

By following these evidence-based strategies tailored to ARDS severity, clinicians can optimize outcomes for patients with this life-threatening condition.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.